Is Paratek Pharmaceuticals Inc (PRTK) a Winner in the Biotechnology Industry?

Tuesday, September 19, 2023 12:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is Paratek Pharmaceuticals Inc (PRTK) a Winner in the Biotechnology Industry?

Paratek Pharmaceuticals Inc (PRTK) is around the top of the Biotechnology industry according to InvestorsObserver. PRTK received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. Paratek Pharmaceuticals Inc also achieved a score of 80 in the Biotechnology industry, putting it above 80 percent of Biotechnology stocks. Biotechnology is ranked 63 out of the 148 industries.

PRTK has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on PRTK!

See Full PRTK Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Paratek Pharmaceuticals Inc Stock Today?

Paratek Pharmaceuticals Inc (PRTK) stock is flat 0% while the S&P 500 is lower by -0.73% as of 12:12 PM on Tuesday, Sep 19. PRTK is unmoved $0.00 from the previous closing price of $2.19 on volume of 3,899,584 shares. Over the past year the S&P 500 is up 13.37% while PRTK is lower by -12.40%. PRTK lost -$1.11 per share the over the last 12 months. Click Here to get the full Stock Report for Paratek Pharmaceuticals Inc stock.